21h
Zacks.com on MSNIs it Worth Retaining QIAGEN Stock in Your Portfolio Now?QIAGEN N.V.’s QGEN fourth-quarter performance was driven by solid potential in molecular diagnostics. The company continues to progress with its test menu expansion, building a solid foundation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results